CMRAW (OTC)
COMERA LIFE SCIENCES WTS
$0.000800
+0.000000 (+0.00%)
Prev close: $0.000800
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals Major
- CEO
- Michael Campbell, CPA
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- —
- Employees
- —
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.00M |
| Benefits Costs and Expenses | $10.01M |
| Cost Of Revenue | $264.88K |
| Costs And Expenses | $10.01M |
| Gross Profit | $735.52K |
| Nonoperating Income/Loss | $137.61K |
| Operating Expenses | $9.88M |
| Research and Development | $1.43M |
| Other Operating Expenses | $8.45M |
| Operating Income/Loss | -$9.15M |
| Income/Loss From Continuing Operations After Tax | -$9.01M |
| Income/Loss From Continuing Operations Before Tax | -$9.01M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $25.18K |
| Net Income/Loss | -$9.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.22 |
| Diluted Earnings Per Share | -$0.22 |
| Basic Average Shares | 63,458,927 |
| Diluted Average Shares | 63,458,927 |
| Assets | $3.07M |
| Current Assets | $2.63M |
| Noncurrent Assets | $441.45K |
| Fixed Assets | $186.74K |
| Other Non-current Assets | $254.72K |
| Liabilities | $2.97M |
| Current Liabilities | $2.93M |
| Accounts Payable | $1.14M |
| Other Current Liabilities | $1.79M |
| Noncurrent Liabilities | $37.27K |
| Equity | -$4.22M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$4.22M |
| Liabilities And Equity | $3.07M |
| Net Cash Flow From Operating Activities | -$6.66M |
| Net Cash Flow From Operating Activities, Continuing | -$6.66M |
| Net Cash Flow From Investing Activities | -$94.01K |
| Net Cash Flow From Investing Activities, Continuing | -$94.01K |
| Net Cash Flow From Financing Activities | $5.85M |
| Net Cash Flow From Financing Activities, Continuing | $5.85M |
| Net Cash Flow | -$901.48K |
| Net Cash Flow, Continuing | -$901.48K |
| Comprehensive Income/Loss | -$9.01M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.01M |
| Other Comprehensive Income/Loss | $0.00 |